BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221010
DTEND;VALUE=DATE:20221012
DTSTAMP:20260516T041142
CREATED:20220511T084634Z
LAST-MODIFIED:20220511T084634Z
UID:34048-1665360000-1665532799@www.pharmajournalist.com
SUMMARY:SAE Media Group's 3rd Annual Wearable Injectors and Connected Devices Conference
DESCRIPTION:SAE Media Group’s 3rd Annual  \nWearable Injectors and Connected Devices Conference \n10 – 11 October 2022 | London\, UK \nhttp://www.wearable-injectors.co.uk/Pharmajournalist \nThe Latest Innovations In Digital Health And On-Body Drug Delivery For The Pharmaceutical Industry \nSAE Media Group’s 3rd annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field\, including the enhanced demand for on-body injectors and digitalised health as the need for at home self-administration and routes for delivery of time-dependent\, high volume and viscous drugs grow. \nBenefits of Attending: \n\nEngage with key regulatory updates surrounding digital health and medical devices\nDiscover advances in device design and development for large volume delivery via on-body injectors\nExplore the key drivers of novel drug products for the development for on-body injectors\nHear insights into the growing potential of digital health to improve patient experience and treatment\nDevelop your understanding of design strategies for connectivity and digital health\n\nDelegates will have the opportunity to network with the following companies: \n\nJohnson & Johnson\nBiogen\nAstraZeneca\nMerck KGaA\nNovartis\nNovo Nordisk\nBoehringer Ingelheim\n\nAnd many more!! \nWho Should Attend: \n\nExecutives\, Directors\, VPs\, Heads\, Principals\, Managers of:\nDrug-Delivery Developers\nAutoinjectors\nDevice Engineering\nHuman Factors\nInjectables\nPackaging\nRegulatory Affairs\nConnectivity\nMedical Device Data\nNovel Product Technology\nSmart Device Developers\nDevice Safety Solution Providers\nor anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals\, biotech\, device developers and solution providers.\n\nThe two-day conference will bring you high-quality insights and industry connections on the latest advances in wearable injectors and connectivity\, and a platform for exchanging ideas. \nFor more information contact: \nNikisha Galoria | Marketing Executive | SAE Media Group \nEmail: ngaloria@smi-online.co.uk \nPhone: +44 (0) 20 7827 6164 \nFollow us on: \nLinkedIn: SAE Media Group Pharma \nTwitter: @SAEMGPharma
URL:https://www.pharmajournalist.com/event/sae-media-groups-3rd-annual-wearable-injectors-and-connected-devices-conference/
LOCATION:London\, UK
ORGANIZER;CN="Hanson Wade":MAILTO:ngaloria@smi-online.co.uk
END:VEVENT
END:VCALENDAR